A study looking at using a cancer support app for people with head and neck cancer (ENHANCE)
This study is looking at using an app to see if it can help support people having treatment for head and neck cancer.
This study is looking at using an app to see if it can help support people having treatment for head and neck cancer.
This study is looking at whether vitamin E and pentoxifylline can prevent tissue damage and a jaw problem called osteoradionecrosis.
A study to develop a way of predicting long term side effects of radiotherapy (Hamlet-RT)
Between 8% and 61% of patients diagnosed with head and neck cancers have chemotherapy as part of their primary cancer treatment.
Between 43% and 85% of patients diagnosed with head and neck cancers have radiotherapy as part of their primary cancer treatment.
Treatment for head and neck cancer varies for each cancer type.
Between 32% to 75% of patients diagnosed with head and neck cancers cancer have surgery to remove the tumour as part of their primary cancer treatment.
This trial is for people with a head and neck cancer that has come back after treatment (recurred) or has spread to another part of the body (metastatic).
This study is open to people whose cancer has spread and who are due treatment with a biological therapy by itself, or with chemotherapy.
This study is open to people going to an outpatient clinic at The Christie Hospital, Manchester.
Difficulty swallowing can be a long term problem for people who have had surgery or radiotherapy to treat a head and neck cancer.